Communiqués Pressure BioSciences, Inc.

Actions

PBIO

US74112E2081

Equipement et technologie médicale avancés

Marché Fermé - OTC Markets Autres places de cotation 18:43:58 23/03/2026			Varia. 5j.	Varia. 1 janv.
0,000500 ^USD	-.--%		-89,36%	-

07/02/25	Pressure BioSciences, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2024	CI
06/09/24	Pressure BioSciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

18/06/24	Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET	AQ
13/06/24	Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET	AQ
11/04/24	Uncle Bud’s Health and Wellness to Expand New Premium Collection with Novel Products for Sleep, Memory, Pain, Immunity, Feminine Hygiene, and Sexual Wellness	AQ
02/04/24	Pressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”	AQ
26/02/24	Uncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.	AQ
15/02/24	Pressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	AQ
05/02/24	Uncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product Effectiveness	AQ
01/02/24	Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds	AQ
22/01/24	Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales	AQ
18/01/24	Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order	AQ
16/01/24	Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January	AQ
12/01/24	Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud's, Forward Integrating PBIO's UltraShear Platform into Multiple Markets	AQ
11/01/24	Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets	BU
05/01/24	Pressure BioSciences BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational Technologies	AQ
22/12/23	Pressure BioSciences Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform	AQ
13/12/23	Pressure BioSciences UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores	AQ
11/10/23	Pressure BioSciences Continues Expansion of IP Portfolio of Revolutionary UltraShear Technology with Award of First Canadian Patent	AQ
11/09/23	Pressure BioSciences BaroFold Technology Achieves Pivotal Equipment Sale and Begins Scale-up in Service to Leading Global Contract Devt. and Mfg. Organization	AQ
31/08/23	Pressure BioSciences Provides Second Progress Report on UltraShear Nano-CBD Launch and Commercialization Program 'Drive to 420'	AQ
18/08/23	Pressure BioSciences Invites Interested Investors to Attend a Webinar on the Health and Wellness Marvels of PBIO's Revolutionary UltraShear Platform	AQ
10/08/23	Pressure BioSciences Reports Strongly Accelerating UltraShear Nano-CBD Orders	AQ
27/07/23	Pressure BioSciences and Master Distributor Canopy CBD Farms Announce Major Increase in UltraShear Nanoemulsion Platform Pipeline	AQ
26/07/23	Pressure BioSciences Launches Program to Evaluate Company's Patented UltraShear Process in Breakthrough Application to Extend Shelf-Life of Fresh Produce	AQ
18/07/23	Pressure BioSciences Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering	AQ
01/06/23	New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads	AQ